Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Home
Clinical development
Phase III
Phase III
Phase III
Study: Isatuximab Combination Provides Unprecedented Median PFS in Treatment of Multiple Myeloma
Peter Hofland, Ph.D
-
May 15, 2022
What to Expect at AACR: Long-term Outcomes for Sotorasib in KRAS G12C-mutated NSCLC
Clinically Relevant PFS: TIVO-3 Trial Confirms Superiority of Tivozanib vs. Sorafenib
Olaparib as adjuvant Treatment in Germline BRCA-mutated HER2-negative High-risk Early Breast Cancer
Pembrolizumab Shows Significantly Prolonged Event-free Survival in High-Risk Early-Stage TNBC
U.S. FDA approves Phase 3 Study Design for Zilovertamab in the...
Editorial Team
-
January 4, 2022
Combination of Plinabulin + Pegfilgrastim in Breast Cancer Improves Health-related Quality-of-Life
Editorial Team
-
December 9, 2021
Elacestrant – First Oral Selective Estrogen Receptor Degrader Shows Benefit over...
Editorial Team
-
December 7, 2021
Phase 3 Zanidatamab Study in First-Line HER2+ Gastroesophageal Adenocarcinoma Enrolls Patients
Peter Hofland, Ph.D
-
November 10, 2021
Patient-Derived Cancer Model for Plinabulin Monotherpy Supports Treatment in SCLC
Editorial Team
-
October 27, 2021
The Path Toward Curative Treatments in Cervical Cancer
Jennifer Buell, Ph.D.
-
October 18, 2021
Novel Imaging Agents in Development for Prostate Cancer
Colin Hayward, MD
-
October 9, 2021
Zanidatamab Shows Promising Response in First-Line HER2-Positive Gastroesophageal Adenocarcinoma
Editorial Team
-
September 21, 2021
Cabozantinib + Atezolizumab Shows Encouraging Activity and Acceptable Tolerability in Advanced...
Editorial Team
-
September 21, 2021
Ribociclib Trial Data Shows Longest Median OS Ever Reported in HR+/HER2-...
Editorial Team
-
September 20, 2021
1
2
3
Page 1 of 3
LATEST NEWS
Combating Financial Hurdles: Setting up Physicians for Short- and Long-term Financial Success
Charlie Nemes
-
May 18, 2022
Researchers Identify a New Subset of High-risk Pediatric Liver Cancer
Peter Hofland, Ph.D
-
May 17, 2022
Polypharmacy – How Cancer Patients Face Higher Risks of Drug Interactions
Leslie Orr
-
May 16, 2022
Study: Isatuximab Combination Provides Unprecedented Median PFS in Treatment of Multiple Myeloma
Peter Hofland, Ph.D
-
May 15, 2022
Bioimpedance Spectroscopy Better than Tape Measure for Preventing Breast Cancer-Related Lymphedema
Sheila Ridner, PhD, RN, FAAN
-
May 13, 2022
X